Nurse Practitioner’s Guide to Prescribing Controlled Substances – Focus on Opioids

22.95
Online
Elective

About the Course


Learning Objectives

  1. Describe the roles of the DEA, FDA, and HHS in scheduling controlled substances and enforcing controlled substance laws and regulations.
  2. Understand the different DEA Controlled Substance Schedules and prescribing regulations associated with the different DEA Controlled Substance Schedules.
  3. Describe important considerations when prescribing any controlled substances, including regulatory exceptions and clinical concerns.
  4. Discuss rationale for using opioids in acute and non-cancer related chronic pain management.
  5. Assess patients to identify and monitor for patient-specific risks of opioid medications.
  6. Differentiate between opioid equianalgesic doses and morphine milligram equivalents (MMEs) and their roles in pain management therapy.
  7. Discuss strategies to ensure appropriate and safe prescribing and use of opioid analgesics in patients with acute and chronic pain.


 

About the Author

Kathleen J. Vieson, PharmD

Kathleen Vieson, PharmD, is a clinical pharmacist living in the Tampa, Florida, area. Kathy graduated from the Ohio State University in 1989 with a Bachelor of Science degree in pharmacy. She gained clinical and hospital pharmacy experience during a general hospital residency at the University of Cincinnati Medical Center. She went on to receive her Doctor of Pharmacy degree from the University of Kentucky in 1991 and completed an oncology specialty pharmacy residency at the Pittsburgh Cancer Institute/University of Pittsburgh School of Pharmacy in 1993. After completing her training, Kathy worked as clinical pharmacist at the H. Lee Moffitt Cancer Center in Tampa, where her experience included oncology, malignant and non-malignant hematology, pain management, critical care, and oncology ambulatory care. Kathy then spent the next part of her career at Gold Standard/Elsevier Clinical Solutions where she served in various roles including oncology specialty editor, managing editor of drug databases, vice president clinical drug information resources (clinical pharmacology and ToxED), editor-in-chief, clinical drug information, and vice president, diagnosis, treatment and care content. During her time at Elsevier, she developed numerous drug information applications, clinical decision support databases and tools, and directed content development for physicians, nurses, pharmacists and patients. Currently, Kathy is the senior director of product management and drug information for MedKeeper, which provides pharmacy workflow solutions, including IV Workflow Management software (PharmacyKeeper).

Want Unlimited CE? Become a Member

Nurse Practitioner’s Guide to Prescribing Controlled Substances – Focus on Opioids

22.95

About the Course


Learning Objectives

  1. Describe the roles of the DEA, FDA, and HHS in scheduling controlled substances and enforcing controlled substance laws and regulations.
  2. Understand the different DEA Controlled Substance Schedules and prescribing regulations associated with the different DEA Controlled Substance Schedules.
  3. Describe important considerations when prescribing any controlled substances, including regulatory exceptions and clinical concerns.
  4. Discuss rationale for using opioids in acute and non-cancer related chronic pain management.
  5. Assess patients to identify and monitor for patient-specific risks of opioid medications.
  6. Differentiate between opioid equianalgesic doses and morphine milligram equivalents (MMEs) and their roles in pain management therapy.
  7. Discuss strategies to ensure appropriate and safe prescribing and use of opioid analgesics in patients with acute and chronic pain.


 

About the Author

Kathleen J. Vieson, PharmD

Kathleen Vieson, PharmD, is a clinical pharmacist living in the Tampa, Florida, area. Kathy graduated from the Ohio State University in 1989 with a Bachelor of Science degree in pharmacy. She gained clinical and hospital pharmacy experience during a general hospital residency at the University of Cincinnati Medical Center. She went on to receive her Doctor of Pharmacy degree from the University of Kentucky in 1991 and completed an oncology specialty pharmacy residency at the Pittsburgh Cancer Institute/University of Pittsburgh School of Pharmacy in 1993. After completing her training, Kathy worked as clinical pharmacist at the H. Lee Moffitt Cancer Center in Tampa, where her experience included oncology, malignant and non-malignant hematology, pain management, critical care, and oncology ambulatory care. Kathy then spent the next part of her career at Gold Standard/Elsevier Clinical Solutions where she served in various roles including oncology specialty editor, managing editor of drug databases, vice president clinical drug information resources (clinical pharmacology and ToxED), editor-in-chief, clinical drug information, and vice president, diagnosis, treatment and care content. During her time at Elsevier, she developed numerous drug information applications, clinical decision support databases and tools, and directed content development for physicians, nurses, pharmacists and patients. Currently, Kathy is the senior director of product management and drug information for MedKeeper, which provides pharmacy workflow solutions, including IV Workflow Management software (PharmacyKeeper).